SHANGHAI, China, Aug. 29 /Xinhua-PRNewswire-FirstCall/ --
China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics", "the
Company"), a leading Chinese firm specializing in the manufacture,
research, development, marketing and distribution of probiotics products,
today announced that Mr. Jinan Song, the Company's Chairman and Chief
Executive Officer, Raymond Li, Chief Financial Officer, and Henry Tai, Vice
President of Corporate Development, are scheduled to present at the Roth
Capital Partners 2007 New York Conference.
    The Roth Capital Partners 2007 New York Conference is a two-day event
featuring presentations and one-on-one meetings with more than 230 growth
companies in a variety of industries.
    Date:                Thursday, September 6, 2007
    Time:                1:30 p.m. EDT
    Venue:               The Westin New York at Times Square
    About China-Biotics, Inc.
    Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the
Company") was founded in 1999 and is one of China's largest suppliers of
probiotics. Probiotics are beneficial live bacteria used as dietary
supplements and food additives to improve intestinal health and digestion.
The Company's product portfolio contains live microbes made with
proprietary technology. Currently, these products are sold over-the-counter
under the "Shining" brand through large distributors to more than 1,000
pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining
is one of the most recognized brands in Shanghai. China-Biotics plans to
expand its retail sales to other major cities in China and will launch 300
Shining brand logistic centers in these cities during the next two years.
The Company's flagship product, "Shining Essence," has been a profit driver
since its launch in April 2001. There is a significant demand for
probiotics for use in the bulk additive market, which is currently met by
imports. China-Biotics is building a new plant which will increase its
production capacity manifolds to capture this market.
    Safe Harbor Statement Under the Private Securities Litigation Reform
Act of 1995: Any statements set forth above that are not historical facts
are forward-looking statements that involve risks and uncertainties that
could cause actual results to differ materially from those in the
forward-looking statements. Such factors include, but are not limited to,
the Company's ability to market existing and new products, ability to
access capital for expansion, changes from anticipated levels of sales,
future national or regional economic and competitive conditions, completion
of the above mentioned contract with Bright Dairy, changes in relationships
with customers, dependence on its flagship product profits and other
factors detailed from time to time in the Company's filings with the United
States Securities and Exchange Commission and other regulatory authorities.
The Company undertakes no obligation to publicly update or revise any
forward- looking statements, whether as a result of new information, future
events or otherwise.
    For more information, please contact:

     CCG Elite Investor Relations
     Crocker Coulson, President
     Tel:   +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com

Link to this page: